MORC1 exhibits cross-species differential methylation in association with early life stress as well as genome-wide association with MDD by V. Nieratschker et al.
OPEN
ORIGINAL ARTICLE
MORC1 exhibits cross-species differential methylation in
association with early life stress as well as genome-wide
association with MDD
V Nieratschker1,2,17, R Massart3,17, M Gilles4,17, A Luoni5,17, MJ Suderman3,6,7, B Krumm8, S Meier1, SH Witt1, MM Nöthen9,10, SJ Suomi11,
V Peus4, B Scharnholz4, H Dukal1, C Hohmeyer1, IA-C Wolf4, F Cirulli12, P Gass13, MW Sütterlin14, B Filsinger15, M Laucht16,18, MA Riva5,18,
M Rietschel1,18, M Deuschle4,18 and M Szyf3,6,18
Early life stress (ELS) is associated with increased vulnerability for diseases in later life, including psychiatric disorders. Animal
models and human studies suggest that this effect is mediated by epigenetic mechanisms. In humans, epigenetic studies to
investigate the inﬂuence of ELS on psychiatric phenotypes are limited by the inaccessibility of living brain tissue. Due to the tissue-
speciﬁc nature of epigenetic signatures, it is impossible to determine whether ELS induced epigenetic changes in accessible
peripheral cells, for example, blood lymphocytes, reﬂect epigenetic changes in the brain. To overcome these limitations, we applied
a cross-species approach involving: (i) the analysis of CD34+ cells from human cord blood; (ii) the examination of blood-derived
CD3+ T cells of newborn and adolescent nonhuman primates (Macaca mulatta); and (iii) the investigation of the prefrontal cortex of
adult rats. Several regions in MORC1 (MORC family CW-type zinc ﬁnger 1; previously known as: microrchidia (mouse) homolog) were
differentially methylated in response to ELS in CD34+ cells and CD3+ T cells derived from the blood of human and monkey
neonates, as well as in CD3+ T cells derived from the blood of adolescent monkeys and in the prefrontal cortex of adult rats. MORC1
is thus the ﬁrst identiﬁed epigenetic marker of ELS to be present in blood cell progenitors at birth and in the brain in adulthood.
Interestingly, a gene-set-based analysis of data from a genome-wide association study of major depressive disorder (MDD) revealed
an association of MORC1 with MDD.
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INTRODUCTION
Early life stress (ELS) is associated with increased vulnerability for
diseases in later life, including psychiatric disorders.1–8 Previous
studies suggest that the effect of ELS on lifelong phenotypes is
mediated by epigenetic mechanisms.9–11 Weaver et al.,12 reported
lifelong epigenetic modiﬁcations of the glucocorticoid receptor
gene (NR3C1) in the rat hippocampus in response to stress
induced by low levels of maternal care. More recent studies in
rodents have reported ELS effects on DNA methylation for
additional genes, including AVP, BDNF, NR4A1, SLC6A4, HSD11B2,
RELN, Esr1 and CRH.13–21 Similarly, in humans ELS has been shown
to be associated with altered methylation of NR3C1, BDNF and
SLC6A4.22–31 Recently, Klengel et al.32 reported that demethylation
of a glucocorticoid response element in the stress response
regulator FKBP5 predicted risk for posttraumatic stress disorder,
and that this association was dependent upon risk allele and
childhood trauma status. Although the above studies focused on
candidate genes, two recent studies investigating ELS effects on
an epigenome-wide level identiﬁed a variety of epigenetic
alterations due to ELS.33,34
Studies of ELS in humans are limited. First, since brains of living
humans are not accessible for epigenetic studies, it is impossible
to ascertain if alterations in DNA methylation of peripheral cells
after exposure to ELS reﬂect brain DNA methylation changes
triggered by ELS. Second, excluding underlying causes of changes
in DNA methylation other than ELS is problematic, as genetic
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background and/or predisposing environmental factors cannot be
randomized and controlled in human studies. And third, to
address the issue of a temporal relationship between ELS, DNA
methylation changes and adult phenotypes, a longitudinal
investigation of a human cohort from birth until adulthood would
be required.
To partially address these limitations, we investigated the
effects of ELS on the methylome using a convergent approach.
This involved: (i) a case–control analysis of human CD34+ cells
from cord blood; (ii) the examination of CD3+ T cells from the
peripheral blood of nonhuman primates (Macaca mulatta) at ages
14–30 days and 2 years; and (iii) the analysis of the prefrontal
cortex (PFC) of adult rats.
To limit the inﬂuence of later environmental factors in human
studies that might affect DNA methylation independently of ELS,
an investigation as early in life as possible must be performed. We
analyzed cord blood, as this is the earliest accessible biomaterial in
humans although we recognize that the DNA methylation pattern
might be impacted intrauterine by multiple exposures. We
focused on CD34+ cells, progenitors of white blood cells, as
white blood cells have an important role in the immune response
of an individual, and they are therefore likely to bear
environmental-exposure-related DNA methylation signatures.35
Any DNA methylation state that is triggered by prenatal stress
and persists later in life in white blood cells must have originated
in progenitor CD34+ cells as they contribute throughout life to the
renewing pool of mature peripheral white blood cells. However,
additional cell-speciﬁc DNA methylation changes, which are not
present in CD34+ cells at birth, are likely to occur during cell
differentiation.
We identiﬁed ﬁve single-copy genes, whose promoter DNA
methylation state of individual transcripts is affected the same
way (hypo- or hypermethylation, respectively) after exposure to
ELS in all the three species, at all the investigated time points and,
in the peripheral tissues, as well as in the rodent brain. A gene-set-
based analysis of available genome-wide association study
(GWAS) data on major depressive disorder (MDD)36 revealed an
association between one of those genes, MORC1 (MORC family
CW-type zinc ﬁnger 1) and human depression.
MATERIALS AND METHODS
For detailed methodological descriptions, see Supplementary Information.
Human cohort
Data were obtained from a cohort of mothers and their infants (n=180)
recruited during the third trimester of pregnancy in the Rhine-Neckar
Region of Germany. For inclusion and exclusion criteria see Supplementary
Information. The study protocol was approved by the Ethics Committee of
the Medical Faculty Mannheim of the University of Heidelberg. The study
was conducted in accordance with the Declaration of Helsinki. All mothers
provided written informed consent before participation.
A structured interview and questionnaires were used for risk factor
assessment (Supplementary Table S1a). A composite score was calculated
to take three different dimensions of stress into account: (a) maternal
psychopathology (primarily depressive and anxiety symptoms); (b)
perceived stress; and (c) socioeconomic and psychosocial stress
(Supplementary Table S1c). Stressful prenatal adverse conditions were
also considered to deﬁne 10 infants with extremely high and 10 infants
with extremely low levels of prenatal ELS, respectively. The sociodemo-
graphic and medical characteristics of the extreme groups are shown in
Supplementary Table S1b. For the comparison of the extreme groups, two-
tailed t-tests for independent samples were used. All results are expressed
as means± standard deviation or as a percentage, as appropriate. The
epigenome-wide data sets of two infants in the low ELS group did not pass
our quality control ﬁlters, therefore, the group size decreased to n=8.
Animals
Rhesus monkeys were reared as previously described.35 Venous blood
samples were obtained from 14–30 days old and 2-year-old monkeys.
Pregnant rats were randomly assigned to control (Ctrl; n=7) or prenatal
stressed (PS; n=9) conditions. The stress paradigm was carried out as pre-
viously described.37 Male offspring PFCs were dissected on postnatal day 62.
In the case of rhesus macaques, protocols for the use of experimental
animals were approved by the Institutional Animal Care and Use
Committee of the NICHD. Rat handling and experimental procedures
were performed in accordance with the EC guidelines (EC Council Directive
86/609 1987) and with the Italian legislation on animal experimentation
(Decreto L.vo 116/92). All animal experiments were carried out in
accordance with the National Institute of Health Guide for the Care and
Use of Laboratory Animals. All efforts were made to minimize animal
suffering and to reduce the number of animals used.
Separation of CD34+ cells from human cord blood
Cord blood was collected immediately after birth and drawn into
ethylenediaminetetraacetic acid (EDTA)-coated tubes. Peripheral blood
mononuclear cells (PBMCs) were isolated through centrifugation with
Ficoll-Paque (GE Healthcare, Munich, Germany), and CD34+ cells were
extracted from PBMCs using the Dynal CD34 Progenitor Cell Selection
System (Life Technologies, Darmstadt, Germany).
Separation of CD3+ T cells from monkey peripheral blood
This was performed as previously described.35 In brief, peripheral blood
was drawn into EDTA-coated tubes. PBMCs were isolated through
centrifugation with Ficoll-Paque (GE Healthcare, Burnaby, BC, Canada),
and T cells were isolated from the PBMCs using CD3+ Dynabeads (Life
Technologies, Burlington, ON, Canada).
Extraction of DNA
Genomic DNA was extracted using Qiagen (Hilden, Germany) or Promega
(Madison, WI, USA) systems, sheared by sonication and quantiﬁed using
the Qubit system (Life Technologies, Burlington, ON, Canada).
Analysis of genome-wide promoter DNA methylation
The procedure used for MeDIP analysis was adapted from previously
published protocols.35,38 Brieﬂy, 2 μg of DNA were sonicated, and
methylated DNA was immunoprecipitated using anti-5-methyl-cytosine
(Eurogentec, Fremont, CA, USA). The DNA-antibody complex was
immunoprecipitated with protein G, and the methylated DNA was
resuspended in digestion buffer (50mM TRisHCl pH8; 10 mM EDTA; 0.5%
SDS) and treated with proteinase K overnight at 55 °C. The input and
bound fraction were puriﬁed, ampliﬁed using the Whole Genome
Ampliﬁcation Kit (Sigma-Aldrich, St. Louis, MO, USA), and labeled for
microarray hybridization with Cy3-dUTP and Cy5-dUTP, respectively, using
the CGH Enzymatic Labeling Kit (Agilent Technologies, Mississauga, ON,
Canada) in accordance with the manufacturer´s instructions. Custom
designed tiling arrays were used (Agilent Technologies). All steps of the
hybridization, washing, scanning and feature extraction procedures were
performed in accordance with the Agilent Technologies protocol for chip-
on-chip analysis. Extracted microarray intensities were processed and
analyzed using the R software environment for statistical computing
(http://www.r-project.org/).
Validation
Gene-speciﬁc validation of MeDIP data was performed applying
quantitative-real time PCR (QPCR) using the 2−ΔΔCt method. Data are
expressed as group means± s.e.m. The Graphpad 5 software was used to
perform one-tailed Mann–Whitney U-tests.
RNA extraction from human cord blood
Cord blood for RNA extraction was collected immediately after birth and
drawn into PAXgene Blood RNA tubes (PreAnalytiX, Hombrechtikon,
Switzerland). RNA was extracted using the PAXgene Blood RNA Kit
(Qiagen). The quality and quantity of RNA samples were analyzed using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Böblingen, Germany). For
one of the infants from the high ELS group, no RNA was available for
analysis.
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Analysis of gene expression in human cord blood
Reverse transcription was performed using the high-capacity cDNA
Reverse Transcription Kit (Life Technologies, Darmstadt, Germany). Gene
expression levels were analyzed using QPCR and the 2−ΔΔCt method. Data
are expressed as group means± s.e.m. Statistical signiﬁcance was tested
using one-tailed Mann–Whitney U-tests.
Pyrosequencing
The promoter region of MORC1 (NC_000003.11, assembly: CRCh37/hg19,
position: 108.838.104–108.838.644) was analyzed by pyrosequencing. In
brief, three fragments of bisulﬁte-treated DNA (EpiTect Bisulﬁte Kit, Qiagen)
were ampliﬁed by PCR (HotStar Taq DNA Polymerase, Qiagen; primer
information see Supplementary Table S2) using an unmodiﬁed forward
primer and a biotin-labeled reverse primer (Euroﬁns, Ebersberg, Germany).
Pyrosequencing was performed using a PyroMark Q24 Advanced system
(Qiagen; primer information see Supplementary Table S2) in accordance
with the manufacturer's protocol. Methylated and unmethylated EpiTect
control DNA samples (Qiagen) were used as controls for bisulﬁte
conversion, ampliﬁcation and pyrosequencing. The percentage of methy-
lation at each CpG site was quantiﬁed using the PyroMark Q24 Advanced
software version 3.0.0 (Qiagen) Sequencing was performed in triplicate.
Quality control ﬁltering and statistical analyses of the pyrosequencing
results were conducted using R Version 2.15.3 (http://www.r-project.org).
Measurements marked as unreliable by the Pyromark software were
removed from the data set. Triplicate measurements were averaged after
the removal of outliers (values deviating more than 3%). A Mann–Whitney
U-test was used to compare the mean percentage of methylation of CpG
sites for the ELS versus control groups. Data are presented as the mean± s.
e.m.
Genetic analysis
Genotypes were investigated using GWAS data of a previous study of
MDD.36 dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP) was searched
for SNPs (single-nucleotide polymorphisms) across the genes. The set-
based test, as implemented in PLINK (v1.0.7)39 was performed (with default
options and 105 permutations), to test for association between MDD and
the whole set of genetic variants in the data set.
RESULTS
Effects of ELS on genome-wide promoter methylation in human
newborns
To shortlist candidate genes that: (i) are affected by ELS in
humans, rats and monkeys; (ii) persist into adulthood; and (iii) are
differentially methylated in both peripheral tissue and the brain, a
series of MeDIP genome-wide methylation analyses were per-
formed. For the human sample, CD34+ hematopoietic stem cells
derived from the umbilical cord blood of extreme ELS groups were
analyzed. A total of 3405 distinct genes were signiﬁcantly
associated with prenatal stress. Of these genes, 1786 were
hypomethylated and 1750 were hypermethylated after exposure
to ELS. For 131 genes, a mixed methylation pattern was observed.
Supplementary Table S3a provides a list of genes associated with
the 25 most signiﬁcant probes. Interestingly, this list includes
B3GAT2 for which an association with schizophrenia has been
previously reported.40
Effects of ELS on genome-wide promoter methylation in
peripheral tissues of nonhuman primates
Persistent changes in gene methylation secondary to ELS
exposure that can be identiﬁed in venous blood cells were of
particular interest, as these genes are of potentially high value in
follow-up studies in humans. Venous blood of human infants
cannot be obtained for ethical reasons. Therefore, the ELS
signature of CD3+ T cells derived from venous blood of newborn
(14–30 days old) and adolescent (2 years old) rhesus monkeys
exposed to different rearing conditions (maternally reared versus
surrogate-peer reared) have been analyzed. CD3+ T cells have
been chosen, as CD34+ stem cells, which are progenitors of CD3+
T cells, are not sufﬁciently abundant in venous blood.
In the CD3+ T cells of 14–30-day-old monkeys, a total of 4924
distinct genes were signiﬁcantly associated with postnatal stress.
Of these genes, 2803 were hypomethylated and 2424 were
hypermethylated in surrogate-peer reared monkeys and 303
genes displayed a mixed methylation pattern. Supplementary
Table S3b provides a list of genes associated with the 25 most
signiﬁcant probes.
In the CD3+ T cells of adolescent monkeys (2 years old), a total
of 2547 distinct genes associated with postnatal stress have been
identiﬁed. Of these genes, 1744 were hypomethylated and 873
were hypermethylated in surrogate-peer reared monkeys and 70
genes displayed a mixed methylation pattern. Supplementary
Table S3c provides a list of genes associated with the 25 most
signiﬁcant probes.
A total of 1180 genes were differentially methylated in both the
newborn and adolescent monkeys (Po2.6E− 10, hypergeometric
test), supporting the hypothesis that ELS is associated with a
pervasive signature in the methylome of CD3+ T cells, which arise
early after exposure, and that a number of methylation changes
persist later in life.
A comparison of genes differentially methylated in human
CD34+ with genes differentially methylated in peripheral CD3+
T cells of newborn and adolescent monkeys revealed an overlap of
176 genes (Supplementary Table S4). Gene set analysis of these
176 genes showed enrichments for biological functions such as
cancer (P= 4.45E− 6) or gene expression (P= 7.44E− 5; data not
shown) suggesting that the overlap may not be random, although
it is not signiﬁcant.
Identiﬁcation of conserved genes responding to ELS in peripheral
tissues and in the brain
To identify which of these overlapping genes are differentially
methylated in the adult brain, the human and monkey data were
compared with genome-wide methylation data derived from PFC
of adult rats. A total of 3385 distinct genes were signiﬁcantly
associated with prenatal stress. Of these genes, 1554 were
hypomethylated, 1973 were hypermethylated after exposure to
ELS and 142 genes presented a mixed methylation pattern.
Supplementary Table S3d provides a list of genes associated with
the 25 most signiﬁcant probes.
By comparing the data derived from human and monkey
peripheral tissue with the rodent PFC data, we identiﬁed 30 genes
(overlap not signiﬁcant) whose methylation status was associated
with ELS in all the tissues and species analyzed (Supplementary
Table S5). Interestingly, this list includes CACNA1C one of the best-
supported and replicated risk genes for affective disorders.41–44 By
restricting the analyses to promoter regions (−2000 to +500 from
the transcription start site) of individual transcripts, we identiﬁed
seven gene promoters whose DNA methylation status is affected
the same way (hypo- or hypermethylation, respectively) in all
species and tissues. U6, PDE4DIP, ADARB2 and MORC1 were
hypomethylated in the ELS groups. 7SK, PRMT5 and CSRNP3 were
hypermethylated in the ELS groups.
Association with depression
MDD is one of the well-established ELS-associated phenotypes.1–4
We therefore took advantage of a previous GWAS study on MDD36
and performed a gene-based case–control analysis to test for an
association between genetic variants in those overlapping genes
and MDD. We excluded U6 and 7SK from our analysis, as multiple
copies of those genes exist throughout the genome. In addition,
we had to exclude PRMT5 and PDE4DIP as no genetic variants in
PDE4DIP and only one genetic variant in PRMT5 were represented
in the quality-controlled GWAS data set. Of the remaining three
genes, MORC1 and CSRNP3 showed a nominally signiﬁcant
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association with MDD (P= 0.00483 and 0.03139, respectively). Only
the association of MORC1 with MDD withstood Bonferroni
correction for the number of genes tested (P= 0.01449), thus
providing evidence that MORC1 is involved in MDD, a stress-
associated disorder. QPCR was used to validate MORC1 methyla-
tion changes observed in human CD34+ cells, monkey CD3+
T cells and rat PFC (Figure 1).
In the human cohort, we attempted to validate the MeDIP
results using a pyrosequencing approach. Pyrosequencing
revealed very high methylation levels and the signiﬁcant
difference between the ELS and controls was not replicated
(Figure 2).
MORC1 gene expression
To investigate whether the observed alterations in MORC1
methylation levels secondary to ELS resulted in differential gene
expression, MORC1 expression levels were analyzed in cord blood
samples derived from the human extreme groups using a QPCR
Figure 1. Expanded views from the UCSC genome browser of the MORC1 gene are depicted. (a) Human CD34+ cord blood. (b) 14–30-day-old
monkey CD3+ T cells (TC/D14–30), 2-year-old monkey CD3+ T cells (TC/2y). Numbers 1, 2, 3 indicate the locations of DNA ampliﬁcation for
QPCR validations. (c) Rat PFC. For each graph, average methylation probe fold differences (Log2) between control and ELS groups, as well as
regions of signiﬁcant differential methylation are shown. The last track shows the MORC1 gene, as taken from the NCBI reference sequences
collection (RefSeq). QPCR analysis of DNA methylation differences in the MORC1 gene between ELS and control groups are displayed. Relative
bound fraction concentrations are shown. Error bars represent s.e.m. The symbol ‘*’ denotes P-values o0.05, as calculated with the
Mann–Whitney U-test. Ctrl, control group; ELS, early life stress; MORC1, MORC family CW-type zinc ﬁnger 1; QPCR, quantitative PCR.
Figure 2. The bar graph shows the mean methylation levels in the
ELS and control group for each of the six CpG sites in MORC1, as
determined by pyrosequencing. In addition, the average methyla-
tion level of all sites is displayed. Error bars represent s.e.m. No
signiﬁcant difference between the ELS and Ctrl group was detected.
Statistical signiﬁcance was calculated using the Mann–Whitney U-
test. Ctrl, control group; ELS, early life stress; MORC1, MORC family
CW-type zinc ﬁnger 1.
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approach. No differences in MORC1 expression were detected
between the high and low ELS groups (Figure 3).
DISCUSSION
The present study is the ﬁrst to apply a cross-species and cross-
tissue approach to the identiﬁcation of ELS effects on the
epigenome. As has been postulated before,45 our data provide
evidence for genome-wide and system-wide changes in DNA
methylation in response to ELS. This information might be useful
in predicting lifelong behavioral and physical phenotypes,
especially as we could identify such changes very early in life. In
this study, differential methylation of 30 genes was associated
with ELS immediately after birth in human CD34+ cells, and
additionally in peripheral CD3+ T cells of newborn and adolescent
monkeys, as well as in the brain of adult rats. A gene-based
case–control analysis to test for an association between genetic
variants and MDD identiﬁed one of those genes—MORC1—as
being additionally associated with MDD on a genetic level in a
different cohort. Our results provide evidence for a link between
the MORC1 gene and depression. MORC1 is an excellent candidate
as an immediate ELS responsive gene as it is differentially
methylated in the brain and peripheral cells at different ages and
could be followed longitudinally in living humans.
Although previous studies reported associations between ELS
and DNA methylation in the adult brain tissue or peripheral blood
cells, critical questions remained unanswered. First, are ELS-
associated DNA methylation changes a consequence of early life
experiences, or a cause of the later psychiatric phenotypes
resulting from ELS? To address this question, we examined
changes in DNA immediately after exposure to ELS. Our data show
that in both, monkeys and humans, DNA methylation differences
emerged soon after ELS exposure supporting the hypothesis that
DNA methylation changes follow ELS, and precede the appear-
ance of the clinical phenotypes later in life.
In humans, disentangling DNA methylation caused by ELS from
DNA methylation caused by other preexisting confounding factors
such as genetic variation and other environmental factors remains
impossible. We bypassed these limitations by applying a
convergent, translational approach comparing human data with
data derived from animal models as they can be randomized to
high and low ELS and their environment can be controlled.
A wide variety of prenatal stressors—including maternal
depression during pregnancy, as well as a multitude of socio-
economic and psychosocial stressors—may result in epigenetic
alterations and long-lasting effects on the health and behavior of
the child. Accordingly, the present study applied a broad
deﬁnition of prenatal stress in humans. However, all subjects in
the high stress group were chronically exposed to multiple
socioeconomic and psychosocial stressors as well as to high levels
of subjectively perceived stress of the mother. The Macaca
mulatta analyses focused on the effects of very early postnatal
stress on the epigenome. This experimental condition was
speciﬁc, standardized and adequately controlled. However, the
comparison of a postnatal stress paradigm in the monkey to a
gestational stress paradigm in humans could be considered a
limitation of our study. Nonetheless, the maternal separation
model for ELS applied in the nonhuman primates leads to
neurobiological, physiological and behavioral consequences
similar to those identiﬁed in humans after exposure to early
adversity.46–49 Our study provides additional evidence that ELS
causes evolutionary conserved differential methylation of respon-
sive genes as has been postulated previously.50
Although we are aware of sex-speciﬁc epigenetic effects, we
decided to study the human offspring of the most stressed
mothers, independent of sex of the infants. As the gender
distribution did not differ signiﬁcantly between the groups, we
would consider this a minor issue. Maternal smoking and alcohol
consumption during pregnancy have an impact on the global
DNA methylation pattern of the infant.51–57 Both were signiﬁcantly
higher in the present high ELS group, and this is an obvious
confounding factor. However, this effect can be excluded if
overlapping differentially methylated genes are found in animal
models of ELS, since these animals were exposed to neither
cigarette smoke nor alcohol during gestation.
We reasoned that there exist robust and fundamental changes
in DNA methylation, which will be conserved not just among
species but also among tissues. The overlapping changes
identiﬁed in both CD34+ and CD3+ cells are consistent with the
hypothesis that changes in methylation in response to ELS appear
early in progenitor cells which are then passed on to their
different daughter lineages. Identiﬁcation of genes that respond
similarly to ELS in brain and blood cells is critical for studying
behavioral epigenetics in humans and for potential diagnostics
and therapeutic interventions. Future studies will be necessary to
identify which speciﬁc cerebral cell subtypes are affected by ELS,
as we analyzed PFC material without isolating speciﬁc cells.
ELS is a condition associated with several health and psychiatric
conditions including depression in later life.1–4 Taking advantage
of an available GWAS in MDD, we were able to demonstrate that
genetic variants in one of those persistently methylated genes,
MORC1, are signiﬁcantly associated with MDD. This supports the
hypothesis that MORC1 is involved in at least one known
consequence of ELS, the risk for depression in later life. The
genome-wide ﬁnding for MORC1 was conﬁrmed in all the three
organisms using QPCR, which is the standard method for
validation of MeDIP-chip data. Unexpectedly, the additional
attempt to replicate the differential methylation of MORC1 using
a pyrosequencing approach failed. One possible reason could be
that the MeDIP-chip does not provide single base resolution, but
instead suggests a region between 800 and 1200 bp harboring
CpG sites of interest. The identiﬁcation of differentially methylated
CpGs in this area via pyrosequencing is hampered by the relative
short (⩽300 nucleotides) sequencing reads, which complicates
selection of the target region for replication. It is therefore
possible that we missed the differentially methylated CpGs.
Furthermore, results obtained by MeDIP and bisulﬁte-based
Figure 3. Relative expression of MORC1 in human cord blood (n= 9
ELS and n= 8 Ctrl). Values are given as mean quantities normalized
by β-actin. Error bars represent s.e.m. No signiﬁcant difference
between the ELS and Ctrl group was detected. Statistical signiﬁ-
cance was calculated using the Mann–Whitney U-test. Ctrl, control
group; ELS, early life stress; MORC1, MORC family CW-type zinc
ﬁnger 1.
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sequencing are not necessarily comparable. For example, in a
recent study by Jenke et al.,58 methylation levels obtained by
MeDIP differed substantially from methylation levels obtained by
pyrosequencing. Furthermore, bisulﬁte conversion of DNA does
not distinguish between 5-methylcytosine and 5-hydroxymethyl-
cytosine, whereas MeDIP using an anti-5-methyl-cytosine is
selective for DNA methylation. We are therefore unable to exclude
the possibility that the region identiﬁed by MeDIP as being
differentially methylated after ELS is additionally differentially
hydroxymethylated after ELS. This could furthermore explain the
very high methylation levels obtained by pyrosequencing.
No signiﬁcant differences in MORC1 expression were detected
in cord blood samples from the human extreme groups.
Unfortunately, no RNA from CD34+ cells was available for our
cohort. Hence gene expression analysis was performed in whole
blood samples, whereas DNA methylation was measured in CD34
+ cells. The cell-type-speciﬁc nature of DNA methylation patterns
could therefore explain this unexpected ﬁnding. A recent study
showed that hypermethylated promoters can be transiently
activated through chromatin remodeling without promoter
demethylation, thus contradicting the common hypothesis that
correlates DNA hypermethylation with silencing of gene
expression.59 This ﬁnding suggests that promoter DNA methyla-
tion might be a programming factor providing an enduring
memory for gene silencing rather than a marker of active gene
expression. Further research is needed to ascertain if this
phenomenon also applies to MORC1 and to investigate the
functional consequences of differential MORC1 methylation in
more detail.
The role of MORC1 is largely unknown. In mammals, MORC1 is
mainly expressed in male germ cells. In the present study, MORC1
expression levels in human cord blood were very low, and this
may have hampered the detection of signiﬁcant differences
between the groups. Germ cell MORC1 expression commences in
early embryonic development and is important for the completion
of prophase of meiosis I during spermatogenesis.60,61
Loss of function mutation in this gene leads to male infertility in
mice. For other members of the gene family, expression is not
restricted to the testis, which suggests a more general biological
function for the MORC gene family. Recent research suggests that
MORC1 itself has a more general biological role, as it codes for an
evolutionary conserved nuclear protein, which may inﬂuence
gene silencing and chromatin structure, possibly through the
detection of epigenetic marks.62–64 The identiﬁcation of MORC1 as
a gene whose promoter is differentially methylated after exposure
to different forms of ELS in different organisms, different tissues
and different time points also suggests that this gene has a more
general regulatory role in response to stress. However, as only
limited knowledge concerning the role of MORC1 in epigenetic
processes is available, the role of MORC1 within the context of ELS
remains a matter of speculation. Systematic investigation of this
question is warranted.
In addition to the identiﬁcation of MORC1 as epigenetically
modiﬁed after exposure to ELS and associated with MDD,
differential methylation in the human sample was observed for
CACNA1C, ANK3 and PCLO, genes that were identiﬁed in previous
GWAS and replication studies of affective disorders.41–43,65
In conclusion, our novel systematic, genome-wide and cross-
tissues–cross-species investigation of the effects of ELS on the
epigenome identiﬁed MORC1 as differentially methylated in all the
three investigated organisms, in peripheral tissues as well as in the
brain and at different time points in the life-span. Furthermore, an
association was demonstrated between MORC1 and MDD, an ELS-
associated disorder. We therefore propose MORC1 as a new
candidate gene for stress-related disorders whose DNA methyla-
tion status: (i) reﬂects ELS; (ii) is amenable to longitudinal follow-
up in peripheral cells; and (iii) may predict the emergence of ELS-
related disorders, such as depression, in later life. This has
important research, diagnostic and therapeutic implications.
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